In clinical studies on aripiprazole for the treatment of schizophrenia, people taking the medication experienced improvements in their schizophrenia symptoms, including hallucinations and suspiciousness, compared to those not taking it. Longer studies also showed that the drug can help keep symptoms from returning.
Aripiprazole has also been studied for treating major depression (when used along with antidepressants). These studies evaluated people who had not responded adequately to antidepressants alone. Adding aripiprazole significantly reduced depression symptoms, compared to adding a placebo (a “sugar pill” with no active ingredient).
Researchers have also studied aripiprazole for treating irritability associated with autism in children (age 6 through 17 years old). In these studies, children taking aripiprazole showed improvement in their irritability symptoms (aggression towards others, deliberate self-harm, temper tantrums, and quickly changing moods), compared to children taking a placebo.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Abilify [package insert]. Rockville, MD: Otsuka America Pharmaceutical, Inc.;2013 July.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: Approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed February 29, 2008.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 7th ed. Philadelphia (PA): Lippincott Williams & Wilkins;2005.
National Library of Medicine (US). Drugs and Lactation Database (LactMED). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT. Accessed April 30, 2007.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click